WithdrawnNot Applicable

Auditory Research in Children Living With HIV Exposure-uninfected (ARCHIVE)

Stopped: Did not receive funding

0Started 2026-01-01

Plain-language summary

To evaluate the association of in utero antiretroviral therapy (ART) exposure and hearing abilities of children who were perinatally HIV-exposed, but HIV-free, stratified by timing of maternal ART initiation.

Who can participate

Age range7 Years – 9 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy infants with delivery at \>36 weeks gestation age * Birth weight \>2500g * No major chromosomal anomalies, neural tube defects, seizures, HIV infection or other medical conditions that influenced neurodevelopmental outcomes and/or confounded the effects of ART and HIV exposure. Exclusion Criteria: * Child being older than the proposed age range * Caregiver's or the child's refusal to participate

What they're measuring

Post Treatment Dichotic Digits Performance

Timeframe: Intervention will be 1-2 months

Trial details

NCT IDNCT06635642

SponsorSan Diego State University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2030-03-31

View on ClinicalTrials.gov More Hearing Loss trials